Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
CytoSorb sales8.83M89.24%
Grant income1.05M10.64%
Other Sales11.4K0.12%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
All other countries18.05M49.67%
Germany12.96M35.67%
United States5.33M14.67%